Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$165.67 - $199.94 $165 - $199
-1 Reduced 0.06%
1,674 $283,000
Q4 2023

Feb 12, 2024

BUY
$151.44 - $200.09 $31,348 - $41,418
207 Added 14.1%
1,675 $330,000
Q3 2023

Nov 13, 2023

BUY
$167.14 - $192.77 $10,529 - $12,144
63 Added 4.48%
1,468 $255,000
Q2 2023

Aug 09, 2023

BUY
$160.94 - $186.23 $20,761 - $24,023
129 Added 10.11%
1,405 $241,000
Q1 2023

May 08, 2023

BUY
$145.48 - $175.02 $185,632 - $223,325
1,276 New
1,276 $212,000
Q3 2022

Nov 07, 2022

SELL
$148.29 - $182.55 $55,163 - $67,908
-372 Reduced 16.72%
1,853 $275,000
Q2 2022

Aug 04, 2022

SELL
$155.97 - $200.09 $148,327 - $190,285
-951 Reduced 29.94%
2,225 $382,000
Q1 2022

May 10, 2022

BUY
$181.39 - $234.03 $2,358 - $3,042
13 Added 0.41%
3,176 $599,000
Q4 2021

Feb 09, 2022

BUY
$193.69 - $247.03 $11,040 - $14,080
57 Added 1.84%
3,163 $772,000
Q3 2021

Nov 12, 2021

SELL
$189.29 - $209.69 $567 - $629
-3 Reduced 0.1%
3,106 $603,000
Q2 2021

Aug 05, 2021

BUY
$155.9 - $187.99 $32,427 - $39,101
208 Added 7.17%
3,109 $579,000
Q1 2021

May 13, 2021

BUY
$144.0 - $169.39 $274,752 - $323,196
1,908 Added 192.15%
2,901 $457,000
Q3 2020

Nov 13, 2020

SELL
$137.1 - $165.37 $136,688 - $164,873
-997 Reduced 50.1%
993 $164,000
Q2 2020

Aug 10, 2020

BUY
$111.92 - $142.53 $110,688 - $140,962
989 Added 98.8%
1,990 $273,000
Q1 2020

May 07, 2020

SELL
$92.66 - $144.94 $140,935 - $220,453
-1,521 Reduced 60.31%
1,001 $118 Million
Q4 2019

Feb 07, 2020

BUY
$116.25 - $133.25 $2,441 - $2,798
21 Added 0.84%
2,522 $334 Million
Q3 2019

Nov 12, 2019

BUY
$112.57 - $128.43 $281,537 - $321,203
2,501 New
2,501 $312 Million

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $83.7B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Evoke Wealth, LLC Portfolio

Follow Evoke Wealth, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Evoke Wealth, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Evoke Wealth, LLC with notifications on news.